GLO1 and neoplasm: Interestingly, xenograft tumor growth is inhibited when Glo1 is silenced in HCC cells carrying genetic amplification but not in cells with normal copies (62), supporting the potential use of Glo1 as target in tailored therapies in patients with genetic Glo1 amplification.